D. Lutje Hulsik

926 total citations
21 papers, 620 citations indexed

About

D. Lutje Hulsik is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, D. Lutje Hulsik has authored 21 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 9 papers in Molecular Biology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in D. Lutje Hulsik's work include Immune Cell Function and Interaction (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and HIV Research and Treatment (6 papers). D. Lutje Hulsik is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and HIV Research and Treatment (6 papers). D. Lutje Hulsik collaborates with scholars based in Netherlands, France and United States. D. Lutje Hulsik's co-authors include Gert Vriend, Winfríed Weissenhorn, Theo Verrips, Hans de Haard, Andrea Gorlani, Robin A. Weiss, Leon Frenken, Christian Cambillau, Edward Dolk and Silvia Spinelli and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Applied and Environmental Microbiology.

In The Last Decade

D. Lutje Hulsik

21 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Lutje Hulsik Netherlands 14 351 232 204 143 107 21 620
Simon Hoffenberg United States 9 342 1.0× 105 0.5× 125 0.6× 176 1.2× 190 1.8× 16 560
Kirilee A. Wilson Australia 10 212 0.6× 106 0.5× 87 0.4× 127 0.9× 120 1.1× 12 487
Angeline Lim Singapore 13 210 0.6× 145 0.6× 105 0.5× 27 0.2× 88 0.8× 17 573
Raiza Bastidas United States 9 703 2.0× 186 0.8× 110 0.5× 144 1.0× 11 0.1× 12 904
C.M. Johnson United Kingdom 6 374 1.1× 89 0.4× 264 1.3× 35 0.2× 151 1.4× 7 783
A. Darveau Canada 12 812 2.3× 45 0.2× 139 0.7× 83 0.6× 66 0.6× 14 1.0k
Cheng‐Yu Chung United States 19 572 1.6× 258 1.1× 126 0.6× 31 0.2× 24 0.2× 29 787
Karin Weening Belgium 15 256 0.7× 72 0.3× 227 1.1× 25 0.2× 132 1.2× 22 656
Marielle Payne United States 8 455 1.3× 53 0.2× 82 0.4× 84 0.6× 261 2.4× 12 701
Nadia Benkirane France 11 391 1.1× 145 0.6× 130 0.6× 49 0.3× 15 0.1× 16 567

Countries citing papers authored by D. Lutje Hulsik

Since Specialization
Citations

This map shows the geographic impact of D. Lutje Hulsik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Lutje Hulsik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Lutje Hulsik more than expected).

Fields of papers citing papers by D. Lutje Hulsik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Lutje Hulsik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Lutje Hulsik. The network helps show where D. Lutje Hulsik may publish in the future.

Co-authorship network of co-authors of D. Lutje Hulsik

This figure shows the co-authorship network connecting the top 25 collaborators of D. Lutje Hulsik. A scholar is included among the top collaborators of D. Lutje Hulsik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Lutje Hulsik. D. Lutje Hulsik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
King, Lisa A., Iris C. Blijdorp, André N. Vis, et al.. (2024). Leveraging Vγ9Vδ2 T cells against prostate cancer through a VHH-based PSMA-Vδ2 bispecific T cell engager. iScience. 27(12). 111289–111289. 1 indexed citations
2.
King, Lisa A., et al.. (2024). Vδ2 T-cell engagers bivalent for Vδ2-TCR binding provide anti-tumor immunity and support robust Vγ9Vδ2 T-cell expansion. Frontiers in Oncology. 14. 1474007–1474007. 1 indexed citations
3.
Guelen, Lars, D. Lutje Hulsik, Edward J. Hsieh, et al.. (2023). Epitope mapping of monoclonal antibodies: a comprehensive comparison of different technologies. mAbs. 15(1). 2285285–2285285. 17 indexed citations
4.
Lameris, Roeland, Adam Shahine, Bart A. Westerman, et al.. (2023). Enhanced CD1d phosphatidylserine presentation using a single-domain antibody promotes immunomodulatory CD1d-TIM-3 interactions. Journal for ImmunoTherapy of Cancer. 11(12). e007631–e007631. 1 indexed citations
5.
Huang, Shuyu, D. Lutje Hulsik, Dietmar M. Zaiss, et al.. (2020). A novel efficient bispecific antibody format, combining a conventional antigen-binding fragment with a single domain antibody, avoids potential heavy-light chain mis-pairing. Journal of Immunological Methods. 483. 112811–112811. 14 indexed citations
6.
Voets, Erik, Marc Paradé, D. Lutje Hulsik, et al.. (2019). Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα–CD47 innate immune checkpoint. Journal for ImmunoTherapy of Cancer. 7(1). 340–340. 56 indexed citations
7.
Dulos, John, Marco Guadagnoli, D. Lutje Hulsik, et al.. (2017). Abstract 2645: Development of a first in class APRIL fully blocking antibody BION-1301 for the treatment of multiple myeloma. Cancer Research. 77(13_Supplement). 2645–2645. 2 indexed citations
8.
Lai, Rachel, M. Benjamin Hock, Jens Radzimanowski, et al.. (2014). A Fusion Intermediate gp41 Immunogen Elicits Neutralizing Antibodies to HIV-1. Journal of Biological Chemistry. 289(43). 29912–29926. 29 indexed citations
9.
Eenennaam, Hans van, Elise A. M. Veraar, D. Lutje Hulsik, et al.. (2013). Abstract 1246: Development of an agonistic antibody against the human T-cell costimulatory receptor CD27 as a potential immunotherapeutic tool.. Cancer Research. 73(8_Supplement). 1246–1246. 1 indexed citations
10.
Weissenhorn, Winfríed, D. Lutje Hulsik, M. Benjamin Hock, et al.. (2012). A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 determinant for neutralization but not for antigen recognition. Retrovirology. 9(S2). 2 indexed citations
11.
Strokappe, Nika M., Marlén M. I. Aasa-Chapman, Andrea Gorlani, et al.. (2012). Llama Antibody Fragments Recognizing Various Epitopes of the CD4bs Neutralize a Broad Range of HIV-1 Subtypes A, B and C. PLoS ONE. 7(3). e33298–e33298. 51 indexed citations
12.
Gorlani, Andrea, et al.. (2011). Antibody engineering reveals the important role of J segments in the production efficiency of llama single-domain antibodies in Saccharomyces cerevisiae. Protein Engineering Design and Selection. 25(1). 39–46. 31 indexed citations
13.
Chassefeyre, Romain, Karin Pernet‐Gallay, Grégory Effantin, et al.. (2011). Charged Multivesicular Body Protein 2B (CHMP2B) of the Endosomal Sorting Complex Required for Transport-III (ESCRT-III) Polymerizes into Helical Structures Deforming the Plasma Membrane. Journal of Biological Chemistry. 286(46). 40276–40286. 87 indexed citations
14.
Solomons, Julianna, Charles Sabin, Yoshiko Usami, et al.. (2011). Structural Basis for ESCRT-III CHMP3 Recruitment of AMSH. Structure. 19(8). 1149–1159. 42 indexed citations
15.
Sabin, Charles, Davide Corti, Víctor Buzón, et al.. (2010). Crystal Structure and Size-Dependent Neutralization Properties of HK20, a Human Monoclonal Antibody Binding to the Highly Conserved Heptad Repeat 1 of gp41. PLoS Pathogens. 6(11). e1001195–e1001195. 67 indexed citations
16.
Hinz, Andreas, D. Lutje Hulsik, Anna Forsman, et al.. (2010). Crystal Structure of the Neutralizing Llama VHH D7 and Its Mode of HIV-1 gp120 Interaction. PLoS ONE. 5(5). e10482–e10482. 30 indexed citations
17.
Morrée, Antoine de, D. Lutje Hulsik, Antonietta Impagliazzo, et al.. (2010). Calpain 3 Is a Rapid-Action, Unidirectional Proteolytic Switch Central to Muscle Remodeling. PLoS ONE. 5(8). e11940–e11940. 21 indexed citations
18.
Hinz, Andreas, Guy Schoehn, Heribert Quendler, et al.. (2009). Characterization of a trimeric MPER containing HIV-1 gp41 antigen. Virology. 390(2). 221–227. 26 indexed citations
19.
Dolk, Edward, D. Lutje Hulsik, Gert Vriend, et al.. (2005). Isolation of Llama Antibody Fragments for Prevention of Dandruff by Phage Display in Shampoo. Applied and Environmental Microbiology. 71(1). 442–450. 96 indexed citations
20.
Oliveira, Luciana Gonçalves de, Tim Hulsen, D. Lutje Hulsik, A. C. M. Paiva, & Gert Vriend. (2004). Heavier‐than‐air flying machines are impossible. FEBS Letters. 564(3). 269–273. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simon Hoffenberg Breakdown of academic impact, for papers by Kirilee A. Wilson Breakdown of academic impact, for papers by Angeline Lim Breakdown of academic impact, for papers by Raiza Bastidas Breakdown of academic impact, for papers by C.M. Johnson Breakdown of academic impact, for papers by A. Darveau Breakdown of academic impact, for papers by Cheng‐Yu Chung Breakdown of academic impact, for papers by Karin Weening Breakdown of academic impact, for papers by Marielle Payne Breakdown of academic impact, for papers by Nadia Benkirane
Rankless by CCL
2026